| Name | Title | Contact Details |
|---|
University Medicines is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Built by science, driven by compassion. Aspenti Health is an innovative, comprehensive clinical drug testing lab that is seeking to redefine the role of the traditional healthcare testing partners. Led by experienced healthcare professionals, we are focused on shaping a future in which we are instrumental in helping our patients meet their recovery goals. We also are investing in our social mission to create lasting and effective impact through community involvement. We believe in improving patient outcomes through enhanced treatment access and patient advocacy. Unlike other testing partners, Aspenti works hand in hand with our care providers in order to better serve our mutual patient through patient-focused services such as mobile testing, data driven digital health integration, thought leadership, and strategic partnerships with leading healthcare and research institutions. It is our vision to enrich every life through diagnostic science and compassionate care.
Vitruvias is a specialty generic pharmaceutical business focused on the development and marketing of generic products with either (i) complex APIs that are difficult to source, or (ii) finished dosage forms that are inherently difficult to manufacture. The highly skilled team at Vitruvias has expertise in all aspects of the pharmaceutical industry, including product development, licensing, regulatory affairs, marketing, financial analysis, distribution, managed care, trade relations and sales.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.
Omasky Group is a Hinesburg, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.